Reaching a genetic and molecular understanding of skeletal development

Developmental Cell

Volumn 2, Issue 4, 2002, Pages 389-406

  Karsenty, Gerard ^a   Wagner, Erwin F ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b RESEARCH INSTITUTE OF MOLECULAR PATHOLOGY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

AGGRECAN; ATRIAL NATRIURETIC FACTOR; BETA CATENIN; BRAIN NATRIURETIC PEPTIDE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR RECEPTOR 1; FIBROBLAST GROWTH FACTOR RECEPTOR 3; GELATINASE B; GROWTH DIFFERENTIATION FACTOR 5; GROWTH FACTOR; GROWTH HORMONE; HIGH MOBILITY GROUP PROTEIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MATRIX METALLOPROTEINASE; MEMBRANE PROTEIN; NATRIURETIC PEPTIDE TYPE C; NOGGIN; NOTCH RECEPTOR; PARATHYROID HORMONE RELATED PROTEIN; PROTEIN C FOS; SMAD3 PROTEIN; SOMATOMEDIN C; STAT1 PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NFAT; TRANSFORMING GROWTH FACTOR BETA; UNINDEXED DRUG; VASCULOTROPIN; WNT PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; BONE DEVELOPMENT; CARTILAGE CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; CHONDROGENESIS; CONTROLLED STUDY; ENCHONDRAL OSSIFICATION; FEMALE; GENETIC REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; JOINT; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; PROTEIN BINDING; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 0036225281     PISSN: 15345807     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1534-5807(02)00157-0     Document Type: Review

References (148)

1. Craniofacial, vestibular and bone defects in mice lacking the Distalless-related gene Dlx5
2. Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor kappaB (RANK) receptors
3. Tumor necrosis factor receptor-associated factors (TRAFs) - A family of adapter proteins that regulates life and death
4. A putative role for c-Fos in the pathophysiology of Paget's disease
5. SOX9 directly regulates the type-II collagen gene
6. Sox9 is required for cartilage formation
7. Noggin, cartilage morphogenesis, and joint formation in the mammalian skeleton
8. Osteoprotegrin-deficient mice develop early onset osteoporosis and arterial calcification
9. The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts
10. Insulin like growth factors and the local regulation of bone formation
11. Patterning mechanisms controlling vertebrate limb development
12. The cellular and molecular embryology of bone formation
13. Regulationof the differentiation and function of osteoclasts
14. Indian hedgehog couples chondrogenesis to osteogenesis in endochondral bone development
15. Dwarfism and early death in mice lacking C-type natriuretic peptide
16. Dissociation between bone resorption and bone formation in osteopenic transgenic mice
17. The spatial and temporal pattern of collagens I and II and keratan sulphate in the developing chick metatarsophalangeal joint
18. Delta-1 negatively regulates the transition from prehypertrophic to hypertrophic chondrocytes during cartilage formation
19. Bone abnormalities in latent TGF-beta binding protein (Ltbp)-3-null mice indicate a role for Ltbp-3 in modulating TGF-beta bioavailability
20. Bone morphogenetic protein-3 is a negative regulator of bone density
21. kB inducing kinase. Identification of a novel TRAF6 interaction motif
22. Carbonic anhydrase II is an AP-1 target gene in osteoclasts
23. Fibroblast growth factor receptor 3 is a negative regulator of bone growth
24. RANK is essential for osteoclast and lymph node development
25. A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development
26. Osf2/Cbfa1: A transcriptional activator of osteoblast differentiation
27. Regulation of osteoclast formation and function
28. Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL
29. Matrix metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones
30. Increased expression of TGF-beta 2 in osteoblasts results in an osteoporosis-like phenotype
31. Macrophage colony stimulating factor restores in vivo bone resorption in the op/op osteopetrotic mouse
32. Fra-1 replaces c-Fos-dependent functions in mice
33. Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene
34. Requirement for NF-kappaB in osteoclast and B-cell development
35. VEFG couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation
36. LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development
37. c-Fos: A key regulator of osteoclast-macrophage lineage determination and bone remodeling
38. The anatomy and development of brachypodism in the mouse
39. Conditional inactivation of VEGF-A in areas of collagen2a1 expression results in embryonic lethality in the heterozygous state
40. The embryonic development of bone
41. Wnt-14 plays a pivotal role in inducing synovial joint formation in the developing appendicular skeleton
42. TGF-beta signalling from cell membrane to nucleus through SMAD proteins
43. Mutations at the mouse microphthalmia locus are associated with defects in a gene encoding a novel basic helix-loop-heliz zipper protein
44. Cartilage morphology
45. Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand
46. Maturational disturbance of chondrocytes in Cbfa1-deficient mice
47. Hedgehog signaling in animal development: Paradigms and principles
48. Osteopetrosis in mice lacking NFkappaB1 and NF-kappaB2
49. Three new allelic mouse mutations that cause skeletal overgrowth involve the natriuretic peptide receptor C gene (Npr3)
50. Characterization of a novel KRAB/C2H2 zinc finger transcription factor involved in bone development
51. Increased bone formation and osteosclerosis in mice overexpressing the transcription factor Fra-1
52. Hoxa-2 restricts the chondrogenic domain and inhibits bone formation during development of the branchial area
53. Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene
54. The genetic transformation of bone biology
55. Localization of RANKL (receptor activator of NF kappa B ligand) mRNA and protein in skeletal and extraskeletal tissues
56. Cbfa1/Runx2-independent decrease in osteoblast proliferation, osteopenia and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor
57. Involvement of Wnt-5a in chondrogenic pattern formation in the chick limb bud
58. Regulation of chondrocyte differentiation by Cbfa1
59. Segregation of TRAF6-mediated signaling pathways clarifies its role in osteoclastogenesis
60. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts
61. Osteoprotegerin ligand: A common link between osteoclastogenesis, lymph node formation and lymphocyte development
62. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation
63. Brachypodism: A recessive mutation of housemice
64. PTH/PTHrP receptor in early development and Indian hedgehog-regulated bone growth
65. Transforming growth factor-beta regulation of bone morphogenetic protein-1/procollagen C-Proteinase and related proteins in fibrogenic cells and keratinocytes
66. A new long form of Sox5 (L-Sox5), Sox6 and Sox9 are coexpressed in chondrogenesis and cooperatively activate the type II collagen gene
67. Collagen types IX and X in the developing chick tibiotarsus: Analyses of mRNAs and proteins
68. A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait
69. Overexpression of Cbfa1 in osteoblasts inhibits osteoblast maturation and causes osteopenia with multiple fractures
70. Coordination of chondrogenesis and osteogenesis by fibroblast growth factor 18
71. TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling
72. The CREB family of activators is required for endochondral bone development
73. The microphthalmia transcription factor regulates expression of the tartrate-resistant acid phosphatase gene during terminal differentiation of osteoclasts
74. Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth
75. The molecular basis of Boston-type craniosynostosis: The Pro148 → His mutation in the N-terminal arm of the MSX2 homeodomain stabilizes DNA binding without altering nucleotide sequence preferences
76. Birth and death of bone cells: Basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis
77. Low-density lipoprotein receptor-related protein-5 binds to axin and regulates the canonical Wnt Signaling Pathway
78. Fosl1 is a transcriptional target of c-Fos during osteoclast differentiation
79. Targeted discruption of the PU.1 gene results in multiple hematopoietic abnormalities
80. Expression and function of Gdf-5 during digit skeletogenesis in the embryonic chick leg bud
81. Development of the metatarsophalangeal joint of the chick embryo: Morphological, ultrastructural and histochemical studies
82. Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin
83. Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia
84. Up-regulation of the chondrogenic Sox9 gene by fibroblast growth factors is mediated by the mitogen-activated protein kinase pathway
85. Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice
86. The novel zinc finger-cotaining transcription factor osterix is required for osteoblast differentiation and bone formation
87. Repression of hedgehog signaling and BMP4 expression in growth plate cartilage by fibroblast growth factor receptor 3
88. Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia
89. SOX9 binds DNA, activates transcription, and coexpresses with type II collagen during chondrogenesis in the mouse
90. Fgf18 is required for osteogenesis and chondrogenesis in mice
91. Fibroblast growth factors
92. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development
93. Fra-1 potentiates osteoclastic differentiation in osteoclast-macrophage precursor cell lines
94. Mutations in CDMP1 cause autosomal dominant brachydactyly type C
95. The growth plate: Cellular physiology, cartilage assembly and mineralization
96. Bone morphogenetic proteins: An unconventional approach to isolation of first mammalian morphogens
97. Chondrodysplasia and neurological abnormalities in ATF-2-deficient mice
98. Atrial natriuretic factor and related peptide hormones
99. Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia
100. Inactivation of MyoD in mice leads to up-regulation of the myogenic HLH gene Myf-5 and results in apparently normal muscle development
101. Overexpression of delta FosB transcription factors(s) increases bone formation and inhibits adipogenesis
102. FGF-signaling inhibits chondrocyte proliferation and regulates bone development through the STAT-1 pathway
103. Msx2 deficiency in mice causes pleiotropic in bone growth and ectodermal organ formation
104. A constitutively active mutant PTH-PTHrP receptor in Jansen-type metaphyseal chondrodysplasia
105. Targeted expression of constitutively active receptors for parathyroid hormone and parathyroid hormone-related peptide delays endochondral bone formation and rescues mice that lack parathyroid hormone-related peptide
106. Hypoxia in cartilage: HIF-1alpha is essential for chondrocyte growth arrest and survival
107. Placental vascularisation requires the AP-1 component fra1
108. Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia
109. Osteoprotegerin: A novel secreted protein involved in the regulation of bone density
110. The transcription factors L-Sox5 and Sox6 are essential for cartilage formation
111. Indian hedgehog signaling regulates proliferation and differentiation of chondrocytes and is essential for bone formation
112. Limb alterations in brachypodism mice due to mutations in a new member of the TGF beta-superfamily
113. GDF5 coordinates bone and joint formation during digit development
114. Activation of Stat1 by mutant fibroblast growth-factor receptor in thanatophoric dysplasia type II dwarfism
115. Skeletal overgrowth in transgenic mice that overexpress brain natriuretic peptide
116. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families
117. T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma
118. Continuous expression of Cbfa1 in non-hypertrophic chondrocytes uncovers its ability to induce hypertrophic chondrocytes differentiation and partially rescues Cbfa1-deficient mice
119. Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3
120. Bone resorption by osteoclasts
121. Inhibition of chondrocyte differentiation in vitro by constitutive and inducible overexpression of the c-fos proto-oncogene
122. Disruption of human limb morphogenesis by a dominant negative mutation in CDMP1
123. A human chondrodysplasia due to a mutation in a TGF-beta superfamily member
124. Osteopetrosis in mice lacking hematopoietic transcription factor PU.1
125. The murine Bapx1 homeobox gene plays a critical role in embryonic development of the axial skeleton and spleen
126. Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function
127. Skeletal malformations caused by overexpression of Cbfa1 or its dominant negative form in chondrocytes
128. Regulation of rate of cartilage differentiation by Indian hedgehog and PTH-related protein
129. MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes
130. Genetic control of skeletal development
131. Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9
132. Recombinant human bone morphogenetic protein induces bone formation
133. Differential regulation of endochondral bone growth and joint development by FGFR1 and FGFR3 tyrosine kinase domains
134. A novel target cell for c-fos-induced oncogenesis: Development of chondrogenic tumours in embryonic stem cell chimeras
135. Bone and hematopoietic defects in mice lacking c-fos
136. Chondrocytes as a specific target of ectopic Fos expression in early development
137. Arrow encodes an LDL-receptor-related protein essential for Wingless signalling
138. Linkage of M-CSF signaling to Mitf, TFE3, and the osteoclast defect in Mitf(mi/mi)mice
139. The status of Wnt signalling regulates neural and epidermal fates in the chick embryo
140. TRANCE is a TNF family member that regulates dendritic cell and osteoclast function
141. kB activation by the TRANCE receptor
142. TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells
143. TGF-beta/Smad3 signals repress chondrocyte hypertrophic differentiation and are required for maintaining articular cartilage
144. Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): A mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro
145. Negative regulation of BMP/Smad signaling by Tob in osteoblasts
146. Tissue specific regulation of VEGF expression during bone development requires Cbfa1/Runx2
147. Targeted overexpression of insulin-like growth factor I to osteoblasts of transgenic mice: Increased t rabecular bone volume without increased osteoblast proliferation
148. Distinct roles of type I bone morphogenetic protein receptors in the formation and differentiation of cartilage